Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial

Crit Care. 2020 May 8;24(1):209. doi: 10.1186/s13054-020-02934-2.

Authors

Constantinos Pantos¹, Ioulia Tseti², Iordanis Mourouzis²

Affiliations

¹ Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Ave.,11527 Goudi, Athens, Greece. cpantos@med.uoa.gr.
² Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Ave.,11527 Goudi, Athens, Greece.

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections
Critical Illness*
Humans
Pandemics
Pneumonia, Viral
SARS-CoV-2
Thyroid Hormone Receptors alpha
Triiodothyronine*

Substances

Thyroid Hormone Receptors alpha
Triiodothyronine